Evaluating the impact of COVID-19 vaccine rollout on the routine immunization system
What is the purpose of this survey?
PATH is seeking to understand the impact of COVID-19 vaccine rollout on routine immunization systems, focusing on learnings from several countries in Africa and Asia. The focus areas for the learnings are the impact on human resource availability, vaccine supply chain including cold chain equipment and transport availability, program financing, and data management systems. We are also interested in understanding and documenting the actions immunization programs have taken to mitigate or prevent any negative impacts associated with the COVID-19 vaccine rollout on these focus areas. In addition, we seek to understand the impact of COVID-19 vaccination activities on conduct of other vaccine campaigns or supplementary immunization activities (SIAs).
Who should complete this survey?
The survey is to be completed by individuals working in a country in Africa or Asia with firsthand knowledge about how the COVID-19 vaccine rollout has impacted routine immunization system or vaccine campaigns and or individuals with firsthand knowledge of actions that have been taken to mitigate or prevent any negative impacts on routine immunization system associated with the COVID-19 vaccine rollout. These individuals include immunization program managers, logisticians, national and regional immunization technical advisory group members involved in COVID-19 decision-making, technical assistance partners working in country or at the regional level in Africa or Asia.
What should you know about this survey?
You are not required to complete all the questions in the survey, please complete only those you have firsthand knowledge on. If you choose, you can terminate the survey at any time. We will keep the answers you provide us confidential. Information you share will be de-identified and will be synthesized with data collected from other respondents and aggregated across countries or regions. Evidence and findings from the survey will be shared with the funder—the Bill & Melinda Gates Foundation—who may use this information to augment their knowledge base of COVID-19 vaccine rollout and learnings about interventions that have been implemented by some countries to mitigate any challenges faced.
How long will it take to complete the survey?
The survey will take around 30 minutes to complete, if you complete all questions, but a reminder only to respond to sections where you have firsthand information.
Who can I direct further questions to?
If you have any questions or concerns, please contact:
Senior Monitoring and Evaluation Officer, PATH
Page 1 of 8